Stimu latio n of g rowth and diffe rentiation of human epidermis by epiderma l g rowth factor (EGF) is med iated b y its binding to speciftc recepto rs. Wheth er EGF rece ptors prima ril y m ediate cell divi sio n or differentiation in hyperpro liferativ e disease such as psoriasis vu lga ri s is unclear.
Stimu latio n of g rowth and diffe rentiation of human epidermis by epiderma l g rowth factor (EGF) is med iated b y its binding to speciftc recepto rs. Wheth er EGF rece ptors prima ril y m ediate cell divi sio n or differentiation in hyperpro liferativ e disease such as psoriasis vu lga ri s is unclear.
To study the pat hogenesis of psoriasis , 4-mm 2 pun ch biopsy specim ens of nonna l, uninvolv ed , and in volved psoriatic sk in were assayed for EGF rece ptors by autoradiogra phi c, immun o hi stochemi ca l, and biochemica l m et hods. Usin g autoradiograph ic and immunohi stochemi ca l methods, basa l keratinocytes were found to co ntain the g rea test number of EGF bindin g sites and immunorea ctive receptors as co mpared to the upper layers of the ep id ermi s in both no rm al ep idermis and pso ri atic skin. No EGF receptor differences between no rm al and pso riati c ep id ermi s were I n nor m al human epidermi s, ep id e rmal g rowth fac to r (.EGF) receptors, as detected by autoradiography following f
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Il EGF bindin g or by immuno hi stochemist r y utili zin g anti-EGF n:-ccptor antibody , we re loca ted primari ly o n th e mito ti ca ll y active basal kerati nocytes and diminished in number as the cell s became more diffe rentiated 11 -4 1. A simil ar distribution of .EGF binding sites wa s found in vitro [5 ] , indicating that this d istributio n is not co ntro ll ed b y the de rmi s. To st udy the ro le of EGF receptors in differentiation, we selected a benign human skin di sease, psoriasis vulgaris, because the affected ke ratino cy tes may ha ve both an ab no rm all y increased proliferative capacit y and an ab norm all y diffe rentiated state. In acti ve pso riati c sk in lesions, as in normal sk in, th e active ly dividin g keratin ocytes arc limited to Manuscript rece ived Februar y II, 1985; acce pted for publi cation September 27, 1985 .
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Abbreviations: BSA: bovine serum albumin EGF: ep ider mal growth fac to r 1-1 J3SS: Hanks' ba!Jn ced sa lt solmion 1-1 EI'ES: 4-(2-h ydroxyeth yl)-1-piperazin e-et hanes ulfoni c acid 1 -ll tP: ho rse radis h peroxidase PBS: phosp hate-b uffered sa line PDGF: platelet-de ri ved grow th fac tor observed in this layer. In the upper laye rs of the epidermis, a 2-fo ld increase in EGF binding ca pacity was observed in pso riati c sk in as co mp ared with normal thin or thick skin. Biochemica l m ethods indicated that [ 125 l]EGF binding was in creased in psoriatic epidermis as compa red with similar thickness normal epid ermis w hen mea sured on a protein basi s. Epid ermal growth fa cto r was shown to in creas e phosphorylation of the EGF receptor in skin. EGF receptors retained in th e non mitotic stratum spinosum and parakeratotic stratum corneum m ay refl ect th e in co mplete, abnorma l differentiation that occurs in active psoriatic lesion s. Alternativ ely, reta in ed EGF receptors may play a direct role in inhibitin g cellular differentiation in th e suprabasa l la yers. J Irwcst Derma tol 86: [260] [261] [262] [263] [264] [265] 1986 th e first 2-3 cell rows in the s tratum basali s , the epidermal cell b ye r closest to the basal lamina. lf.EGF rece ptors were simpl y a marker of mitotica ll y active cell s, then the mito ti ca ll y active basa l cell laye r in ac tive pso riati c lesion s shou ld be the major site of in creased numb ers of EGF receptors. Co nversely, if EGF receptors va ri ed as a fun ct ion of e piderm al diffe re ntiati o n, a n increas ed numb e r of EGF rece pto rs sh o u ld b e noted through out th e abnorma ll y differenti atin g psoriatic epidermis . Previous s tudies had shown that large numbers of EGF receptors were present on cell s in hum an skin th at are m e tabo li ca ll y very active but mitotica ll y ina ctive s uch as sweat du ct epith elium [2] . Ep idermal g row th factor receptors arc also found o n mitoti ca ll y in ac ti ve arrector pili muscle and sm ooth muscle sites thro u g hout th e body 11 0]. Therefore, the co rrel ation of .EG F recepto rs with rapid cellula r proliferation is impe rfect [11j. The prese nt st udies indicate that a co nsistent in crease in the numbe r of.EGF rece ptors is present in pso riati c lesio ns. However, the in creased number of EGF recepto rs in active lesions was due to a pe rsi sten ce ofEGF recep tors primarily in sites o f abno rmal differentiation and not cellular div isio n. T herefo re, abnorma l EGF receptor m etabolis m m ay pla y a ro le in th e path ogenesis of the beni g n human h y pe rproliferative sk in disease , pso ri asis v ul ga ris .
MATERIALS AND METHODS
Reagents Epiderma l g rowth factor was purchased from Col- (12) , to a specific activity o f1.5 X 1 0~ cpm/ ,u.g . The [
125 l]EG F bound to A-431 cell s and fibr o bl as ts in a concentrati on-dependent, saturable, and rever s ibl e mann er (1 3, 14) . Excess unlabeled (2 ,u.g) E GF was added aft e r ( 125 I) EG F bindin g to sho w th e ex tent of nonspecifi c o r nondis placea blc [
125 l]EGF. L oca li za ti o n of ( 125 l) EGF binding sites by auto radi og raph y in sec ti o ns of hum an skin w as perfo rmed as previo usly described (1, 2) .-In brief, skin sa mples w ere sli ced into very sm all pieces (1 111111 2 ). Samples we re in cubated fo r 90 min at 25°C w ith shakin g in a m edium consis ting of 0. 5 ml HE SS containing 1 mg/ ml BS A , 20 mM 4-(2-h ydroxyeth yl)-1-piperazin ee th anes ulfo ni c acid (HEP E S) pH 7 .4 (binding buffer), and 10 ng/ ml ( 125 1] EG F. Unbo und E G F was rem oved by repea ted was hes in the binding buffe £' at 25°C. All skin sa mples we re fi xed fo r 4 h in 10% neutral b u ffe r e d fo rmalin and processed fo r li ght m ic roscopy in paraffin . Sectio n s (6 ,u.m) we re dipped in a I: I mixture o fNTB-2 emulsion an d di s tilled wa ter. Follow in g ex pos ure at 4°C for 4-1 2 weeks. the e mulsion was develo ped fo r 2 min in Kodak D-19 de velo per at 10°C. Secti ons w ere stain ed w ith hem atoxy lin and eosin and mo unted in Perm ount. Ph otograph s w ere m ade usin g an O lympus PM-1 0-M mi crosco pe w ith bo th bri ght-fi eld an d dark-fi eld ill umin ati on .
EGF Receptor Antiserum-Production and Charact erization The affinit y-purified EG F rece pto r preparati on , used to immunize rabbits to produ ce a specifi c an tise rum to the receptor, w as prepared as previ ously described (15 , 16] . Briefl y, the EGF r ecepto rs fr om A-43'1 human epith elioid ca rcin o m a membra n e ves icles we re solubilized at1d place d on an EG F affinit y column . The receptor w as eluted with 5 mM ethano lamin e, pH 9. 7, co ntainin g 10% glycerol and 0.2% Triton X-100 and th en electro ph oresed b y the m eth od of Laemmli (17) . The Cop massie Blu e-s t ained receptor band w as then cut out and appro)(imately S p.,g r eceptor pro tein inj ected into the rabbit in co mplete Freun d 's adjuva nt. On e w eek later, antiserum collecti on was begun . The IgG f r ac ti o n o f th e anti se ru m was pur ifie d b y amm onium sul fa te precipitati o n (l i? ]. T he annse rum (no . 163) cross-reac ted anc;l Immun o precipitated nati ve EGF rece ptors fro m a number o f norm al tiss u es including no rmal hum an skin (1 ,2] and pl acenta (1 9] . The an tiser a also cross-reacted w ith prec urso r and intrace llular degrada ti o n fo rms o f the EG F receptor (1 5, 16] .
Localization of Immunoreactive EGF Receptor Molecules C ryos tat-secti oned tiss ue secti ons (4-6 ,u.m) we re fi xed in 2.5°/~ g lutara ldeh yde in ph os ph ate-buffered salin e (PBS) , pH 7.4, for 15 min at 25°C. The secti ons were rinsed and then in cubated 15 m in with 3% goat serum and lmg/ ml g lyc ine in PBS . Sections were treated fo r 4 h at 25°C w ith either purifi ed no rmal rabbit !gG o r anti-EG F rece pto r lgG diluted to· 0.05 m g/ml in goa t serum/glycine/ PBS . After ex tensive w as hing; the secti ons we re incu b a t ed for 1 h w ith goa t antirabbit IgG conjuga ted to HRP diluted to 1 : 100 in goa t se rum /glycine/ PBS. Afte r rinsing , tiss ue sectio n s we re reacted w ith 0.05% diamin obenzidine and 0.01% H 2 0 2 in 0.05 Tris buffer at pH 7.6.·
EPIDER M A L GHOWTH FACT O H RECE PTORS IN PSORI AS IS 261
[I 25 1]EGF Binding Assay Th e epidermis was se parated fro m the dermis by in cubation o f 4-mm 2 pun ch biopsies in 1 M N aBr fo r 1 h at 37°C. Th e epidermis vvas w as hed once w ith PBS and th en cut in to 16 pieces . Each piece of epidermis fro m no rmal thi ck or in volved and unin volved psori ati c skin w as additi onall y sliced ho ri zo ntall y so that th e thicknesses of the pieces we re simil ar. This tiss ue size (0.25 mm 2 ) was chosen because sm aller sa mples we re too diffi cult to handle and larger sa mples bo und less EGF at ea rl y times, pres um.a bl y due to a slo w ed penetrati on o f the li ga nd s thro ug h the bi gger sa mples (data no t shown). A single pi ece o f 0.25 mm 2 was used per assay w ith an interassay vari ati on of approximately ± 10%. U sin g this sa mple size, it was then poss ible to m eas ure to tal EG F binding , notis pecifi c bindin g, and to perform m orpholog ic studies fro m a sin gle bio psy. The bindin g mi xture in a to tal volum e of 0.1 ml contained 50 ng/ ml of [l 25 l] EG F in binding buffer at 25°C fo r the indi ca ted times . N onspecifi c bindin g was defin ed as [ 125 1J EG F bo und in th e presence of a 1 00-fold excess of unlabeled EGF and generall y ranged between 35-45% o f the to tal counts bound by the 0.25-mm 2 sa mpl es under o ptim al conditions. To terminate the binding reacti on, the med ium was rem oved by as pirati on and the sa mples was hed once in ice-co ld bindin g bu ffer and then was hed tw ice w ith bind ing bu ffer witho ut B SA . Sa mples we re transferred to . 1 2 x 75-mm tubes, so! .. D:Ii zed in 0. 1 ml 1 M N aO H fo r 1 h at 37°C, and radioacti vity m eas ured in a -y-specrro m eter. The protein content of each epiderm al sa mple was determined by the m eth od o f Low ry et al (20) .
EGF-Stimulated Phosphorylation Assay Frozen hum an m ammary epidermis was sc raped o ff the de rmis and immedi atel y placed in ice-cold PB S. The broken epidermis w as pelleted by centrifu ga tion at 8,000 g for 5 min . It w as then ho mogeni zed in a 10 x volum e eth ylene glyco l bis(/3-amin oethyl ether)N , N , N , N tetraaceti c acid , 3 m M iodoaceti c acid in 20 mM HEPE S buffer, pH 7. 4, usin g a g ro und-g lass ho mogenize r· . Nuclei and . u nbro ken cells were precipitated by centrifu ga ti on at 600 g spin . The membrane fraction of the supern atants was precipitated by centrifugation at 100,000g fo r 1 h. Th e pellet was res uspended in 20 mM H E PES buffer, pH 7.4. A-431 cell m onola ye rs grown as prev iously described (13) we re w as hed 3 times w ith PBS , scraped, and ho m ogeni zed in the ho m ogeni za ti on buffer. T he m embrane fr acti on o f th e supern atant was precipitated and suspended as describ ed above.
Th e phosphorylati on assay mi xture contained 75 J,t g epidermal membranes or 15 ,u.g A-43 1 membra nes, 0.1 % T ri ton X-100, 2 m M Mn C I 2 , 10 J.t M va nadate, 0.25 m g/ ml BSA , 1 ,u.C i [-y-32) AT P (5 C i/,u.m ol) (! C N , Irvin e, Califo rnia) in 20 mM HEPES, pH 7.4, in the absence o r presence o f 10 ng / ,u.l EGF in a total volume of 60 ,u.l. T he reacti on proceeded fo r 10 min at ooc and was stopped by the addition of60 ,u.l o f 2 X Laemmli sa mple buffer (1 7] . After hea tin g the sa mples to 95°C fo r 5 min , they we re pl aced o n a 6% po lyac rylamide gel, electropho resed , and the dried gel placed against a shee t o f Kodak X -0 O m at AR film . The film was exposed at 70°C w ith a Dupont Lightening Plus sc reen fo r one day.
Protein and DNA Assays Protein content was determined by the m ethod o f Low ry et al [20] using BSA as a standa rd. O pti ca l densities we re read at 500 nm on a Gilfo rd 2600 spectropho tom eter. Additional sa mples we re used to m ake determin ati ons o f D NA by the method of Erw in et al (21] . Fo r D N A analys is, a 4-mm 2 pun ch bio psy was in cubated in 0. 5 ml N aBr (Fisher, Sprin gfield , N ew j ersey) fo r l h at 37°C. Following a rinse w ith PB S, th e epidermis was peeled away and solubilized fo r 1 h at 37°C in 0. 1 ml of N aO H . T o the solubilized epiderm is or 100-,u.l aliquots o f ca lf th y mu s D NA (Wo rthington, N ew J ersey) , 0.5 ml of trichl o roaceti c acid was added and the mi xture hea ted at 90°C for 30 min . Supernatants we re cooled to 4°C and mi cro fu ged fo r 5 i11in ._ Sup ern atants were in cubated at 60°C fo r 1 h with 100 ,u.l o r 200 m g/ ml 3,5-diamin obenzoic acid H C l (Aldrich, Milwa ukee, Wisconsin). Th e reaction was sto pped by the addition bindin g s ites in nor m al hum a n s kin we re found primaril y in the b asa l a nd suprabasa l keratino cytcs I I .2 1. Thi s EGF bindin g was specifi c, sa tu_rablc , and re vers ib le. The numb e r o f EGF re ce ptors as m eas ured b y an ultrast ru ctural m e th o d w ith an a nti-EGF rece pto r antibody in th e sa m e skin samp les co rre lated well wit h previou sly reported [ 125 l]EGF bindin g s ites 11 ,2 J and the qu antitative autoradio g rap h y (Table !) . When bi o psies from pso riatic lesions we re in cubated in J 125 !J EGF, a marked in c rease a nd a lteration in di stribution of specifi c labelin g was o bse rved (Fig I C, D , Table 1 ). In creased [ 1~5 IJ EGF bindin g was due to the in creased prese nce of bindin g sites in the upper strata of th e e pidermis as we ll as a subs tantial in crease in epidermal thi ckness in p so riati c skin (Fi g 1 C, D) as co mpared w ith uninvo lved adj acen t epidermis from the sa m e p atient (F ig 1 A, B) and no rm a l skin (data not show n ) J1 ,2]. T he in vo lved pso ri ati c ep idermis was more cellu la r (Fig 1 C, D) than '' unin vo lved" epidermis (F ig 1A,B). The number of sil ver g rain s (representin g JL 5 I]EGF bindin g) in psoriati c epid ermi s was also hi g hest over those a reas th at co ntained the greatest density of nu c le i (F ig I D). Nuclei were prese nt in the uppe r psoriatic epidermis in parakera totic fo c i, and [ 125 1J EGF bindin g activit y was heavier in th ese areas . In reg io n s wh e re n o rm a ll y differentiatin g co rn cocy tes (with o ut nu cle i) we re prese nt, n o s il ver g rain s w e re present (d a ta not s how n).
M orp hometri c analys is o f silver g rains was co ndu cted o n psoriatic lesion s. A !thou g h th e lower e pide rmal co mpa rtment (d efin ed as the first 3 basa l cell layers of bo th pso ri atic a nd norm al s kin ) had a simi lar ca pa city to bind EGF. the uppe r co mpartm ents did n o t have the sa m e EG F bindin g ca pacity (Ta ble I}. Approximatel y twi ce as 1iu n y g r ain s were detec ted in the uppe r co mpartm ents of pso riati c skin ::ts we re found in no rm a l skin (Tab le !) . In co nclus io n, EGF bindin g in activ e pso ri atic les io ns is unu su al in that th e bindin g sites we re not primari ly loca lized to the s tratum basa lis as was EGF bindin g in n o rma l s kin [ 1, 2 J.
An apparentl y p arado x ic res u lt is observed w he n the g rain s per square micrometer arc co mp ared be tween pso riatic and thin e pidermis . T hi s is a so m ew h at invalid co mpariso n s in ce th e basa l la yer (w hi ch binds ve r y hi g h level s of EGF) in thin s kin represents pro po rti o nate ly a hi g her es timated percenta ge o f th e epide rmi s than in psoriati c sk in (53'Yo vs 25 %, res pec ti ve ly; Table II ) . Thus, pso ri atic s kin mus t be compared w ith skin of s imi lar thi ckn ess in this respec t.
U11iii i!O i11Cd Psoriatic Sk i11 : In 3 o f the 12 patients, th e s kin adja cent
to th e activ e psoriati c les io n s was clini cally no rm al. H owever, by hi stologic exa mination , a sli g ht in c rease in epiderma l thickness was n o ted (Fig 1 A,B) . The pattern of J 1~5 !lE GF bindin g was interm ediate be tween that of n o rm::t l skin and apparently no rmal unin vo lved s kin taken from a distant s ite fr om a pso ri at ic patient. There fore , th e intensity of[ 125 1jEGF bindin g in " unin vo lve d " skin va ri ed from levels tha t ap proached th ose seen in th e active les io n s, D) skin of a pso riatic patient we re incub ated w ith 1 '~5 11 EGF. sectio ned, and processed for aut oradiog raph y. Th e emu lsion was cxposl·d for 10 weeks, the section stained wit h hematoxylin and eos in, and vie wed by li ght-and dark-fi eld mi crosco p y as described in t\lclfcrials ""'' Mctlt ods. In dark-l'ldd mi crosco py the silver g r:~in s representin g I '~" I I EGF binding sites arc white (A ,C). whereas the sil ve r g rain s in bri ght-field arc bbck (B, D). In in vo lved ep idermis the sil ver g rai ns arc seen thro ughout th~ ep id ermi s (C) , whcrl' <lS in th e unin vo lved epide rmi s (A) th e sil vn grains arc heavi ly co n cc ntr:~ted ove r the str at um ba salis (h) and th e lowe r strat u m spin os um (s). T he dermi s (d) and skin s urf:~cc (./) arc visible. S i;:c ht~rs = 100 f.Lm .
i. e. , pc ril es io nal skin , to le ve ls w hi ch we re the sa m e as th ose obse rved in s kin sa mpl es taken from n o rm a l and n o npso r ia ti c patients Jl ,2 J.
Biochemical Characterization ofEGF Binding
Hum an epider mis was readi ly se parated fro m the der mis b y in cubatin g th e 4-mm~ pu n ch biopsies fro m n o rm a l thi ck and thin skin in I M NaBr a t 37°C fo r I h. Excellent se p arati o n of th e psoria ti c epidermis fr o m the dermis was als o possible d es pite th e aca nth otic and papi llo ma to us nature o f m a n y s pecim ens (Fig 2) . Under th e sa m e co nditi o ns, I M NaBr h ad n o detec tab le effec t o n J 125 1J EGF bindin g to A-431 cell s o r iso lated human ke ratin ocy te membranes (data n o t show n) . In ag ree m e nt w ith the morphologic data (line 3, Tab le I) J 1~5 1 j EGF bindin g capacit y was hi g hest in n o rm al thi n skin, inte rm ediate in pso riati c skin, and lowest in n o rm al thick skin w he n ca lcu lated o n a milli g ram protein ba sis (Fi g 3) . Thu . th e g rea ter the perce nt age o f th e basa l b ycr to w ho le epidermis. the g rea ter the capa cit y of th e w ho le e pide rmi s to bind EGF. Table II Se parating th e va ri o u s cell laye rs fr o m n o rm al and pso ri a ti c s kin to qu a ntify th e I 125 1J EG F bindin g pe r indi vidual la ye r was te chni ca ll y unsatisfacto ry beca use thi s se parati o n required pro lo nged ex posure to pro tea ses s u ch as tr y psin that affec ted the EGF binding (da ta no t s hown).
N o rm ali za ti o n of t he I 125 1 JEGF bindin g pe r un it of DNA Indicated that ac tiv e pso ri at ic le sio ns m ay actually ha ve a d ecreased EG F bindin g ca pa cit y (T a ble II ) . These data a1-.: misleadin g si nce the proportion o f nu cleated o r DNA -co ntainin g ce ll s differs marked ly in thin , t hi ck . and pso ri atic epide rmi s: Sin ce basa l kc ra tinocytes ha ve th e g rea test ca pacity to bind EG F (T a ble I) I 1 .2 1. the e p ide rm al layers that have th e g reatest propo rti o n o f their nucleated ce ll s as basal ke ratin ocy tes s ho uld have the g reates t EG F b indin g ca pac it y pe r unit of DNA , i.e., no rmal thin e pide rmis . T hi s relatio ns hi p am o ng ba sa l kcratin ocy tes. nucl e:ned ce ll popu la ti o n s, a nd tota l EGF bindin g per unit of DNA is indeed o bserved (T a ble II ).
EGF-Stimulated Phosphorylation in Normal Human
Epidermis To determi ne w he th e r the EGF re ce pto r in n o rmal huma n s kin has EGF-s timul atablc autoph osp ho r yla tin g acti v it y s irnil a r to th at obse rved in o th e r t iss ues, a phos phory lat io n assay was perfo rm ed usin g epide rm al m e mbranes and A-43 1 ce ll s. Th e p hosp ho rylated m cm bra nes we re so lubilize d , pl aced o n a po lyac r y la mide ge l. a nd electro phoresed (F ig 4). As o bse rve d in othe r tiss u es /22,23 ), the m ajo r ph os ph o rylated band w hi ch wa s s timu la t ed b y EGF had a m o lecul a r we ig ht o f 170,000 . A-43 1 m e mb r a n es, phos pho r ylated und er th e same co nditi o ns, were in cluded in thi s ex pe rim ent to s how that th e ph os ph o r y bred band in no rma l human s kin had th e sa m e elec trop horeti c m o bility as the we llstudied EG F receptor of 170,000 da lto ns in th e A-43 1 cell s [23-25 1.
A trace of partiall y deg rad ed EGF receptor (M,. = 150,000) is also vis ible. Und e r the co nditio ns used . EGF did no t affe ct the ph ospho rylatio n of o th e r m e mbran e protein s in t he e xtracts of no rm al huma n s kin (Fig 4) . o ut all epiderm al laye rs. In no rmal epid ermis , the immun o precipitate is found o nl y in the stratum basa lis and st ratum spin osum and is absent in corneocy tes (F ig SD) . In contrast, w hen preimmune lgG was used in place of the specifi c anti-EGF receptor antisera, no specific sta inin g was observed (Fi g SB). The immun oreactive EGF rece pto rs as loca li zed by th e immun o peroxid ase m ethod had th e sa m e qualitative distributi o n as th e E G F rece pto rs locali zed b y auto radi ograp h y of [ 125 I] EG F bindin g sites. Thus, EGF recep tors ap pea r to be reta ined througho~t the en tire thickness o f psoriatic epidermis. In contrast, immuno reacti ve EGF rece p to rs arc absen t in the stratum co rn eu m in reg ress in g pso ri ati c les io ns (und ergo in g success ful treatment) (F ig SC) . H owever, receptors were still present in the stratum basa lis, sp in os um , and gra nul osum . T his decrease o f EGF rece ptor density in the more di ffe rentiated upper epiderm al strata m o re close ly resembles the pattern of immun oreactive EGF recepto rs that is present in no rm al hum an epiden11 is of compa rab le thickness (F ig 51 ).
D ISCUSS IO N
The present stud y ind icated th at the distribution o f f 125 I]EGF bindin g and immun o reacti ve EGF recepto rs was altered in ac tiv' e lesions of psoriasis vul gari s in that twice as m an y EGF receptors were presen t in the upperm ost laye rs of sk in w hen co mpared w ith normal skin . Th e distribution of EGF recepto rs in regressin g psoriatic les io ns· appea rs to be simil ar to that of active psoriatic les io ns, with the excepti o n of the strat um corn eum , w here both EGF rece pto rs and nu clei have begun to d isa ppea r. In th e immun o histochemical stud ies , the anti-EGF receptor antibody used recogn izes bo th occupied and unoccupied EG F receptors, precursor forms of th e EGF recepto r, an d degraded forms of the EGF receptor [1 5, 16 [. Therefo re, th ese 2 m ethods we re useful to determine the va li d ity of the EGF rece pto r loca li za ti o n, as each method studi ed different aspec ts of the EGF rece pto r-under different co nditio ns bu t in the sa m e sam ples. Biochemical measurem en t of the EGF binding also showed that there was an increase in EGF receptors in psoriatic skin as co mpared w ith Figure 5 . 1mmunope roxid ase stainin g of EG F receptors in normal and psoria ti c ep idermis. Punch biopsy specimens from in vo lved psoriatic lesions (A ,B) , treated psori atic les ions from th e sa me patient (C), and normal thick palmar skin (D) were sectioned, was hed , in cubated with norm al IgG (B) or wit h specifi c anti-EGF recepto r IgG se ra (A,C,D). and processed for immunoperox idase sta inin g as prev iously described 121 and in Mlllcrials and Methods. In active psori atic lesions (A) , immunoreactive EGF recepto rs we re present in all epidermal layers, whereas no specifi c staining was seen in th e preimmune cont rol sections (B) . When the lesion bega n to reg ress while the patient was receivi ng UV therapy, immunoreactive EGF receptors we re markedly reduced in the stratum co rneum (C). In co mparab ly thi ck norm al hum an sk in , immunoreactive EGF recep tors were primaril y prese nt in th e stra tum basalis and nea rl y absent from the stratum granu\osu m and stratum co rn eum . S iz e l ;ars = 100 Ji-m.
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normal skin o f co mparable thickn ess . P ersisten ce of [ 125 I] EGF binding and immunoreactive EG F rece pto rs in the active lesio n s o f psori as is v ul ga ris suggests that EGF m ay have a rol e in e pidermal ho m eostas is. The d ecrease o r return towa rd no n nallevels and distributi o n of EGF rece pto rs in regressin g lesions of pso ri as is vul ga ri s could have impo rtant impli cations in the clini cal nu nage m ent of this disease.
In o ur prev io us studies o n no rmal human epidermis [1 ,2] , f 125 !J EGF binding o r immun o reactive EGF receptors primaril y occurred in the first 2 o r 3 layers of basal and suprab asa l keratinocytcs . In the present stud y, th e le vel of EGF recepto rs d e tected in th e ac ti ve les io ns of ps <: . > riasis was also hi g hes t in the lo we r co mpartm en t and did no t sig nifi ca ntl y di ffer in numbe r of EGF rece pto rs. T hu s, ou r data d o no t support th e hy po thesis that an in crease in EG F receptors should occu r o nl y o n th e mitoti call y ac tive ce lls in psorias is. These data are in acco rd with previous studies show ing th at, even in psoriasis, the dividin g cells were found primarily in the first 3 laye rs o f basa l and supra basa l k e ratin ocy tes [6] [7] [8] [9] . How th ese findi n gs relate to the abn o rm al proliferati o n in psoriasis and abn o rmalities in o ther hormonal and en zy m atic d ifferences in pso ri ati c skin such as cy clic nucl eo tides \26\, phospho lipase A2 [271, calmodulin [28, 29] , o r plasma m e mbrane g lycop rotcins [30-32] is unknown . Our prelimin ary studies wit h o th er h yperprolifcrati ve skin diseases (lichen pl anus, verruca vul ga ri s, cond y lo m a acumin atum , basa l cell and squ a m o us cell ca rcino m a) have no t produ ced the same distribution of EGF recepto rs seen in pso riasis v ul ga ris. Whether these [ 125 l)EGF bindin g sites and irnmun o reactive EGF recep tors detected in the involved psoriatic skin in the present stud y represent biolog ica ll y active EGF receptor with its associated tyrosyl kinase ac tivit y is also not known . Epidermal grow th factor stimulated the phosphory lation of a 170,000 d alto n protein in ex tracts of no rm a l hum an ep idermi s (Fig 4) , pres umptively the EG F recepto r w ith its intrinsic ty rosine kin ase activity. How ever , Ge ntlem an et a! [33] recentl y showed that tyrosy l kinase and ph osp hotyrosy l phosphatase ac tivity were in creased 2-fold in active les io ns of pso ri as is co mpared w ith uninvo lved skin. In thei r studies the tyrosy l kinase activ it y in these studies was not stimul ated b y EGF o r platelet-derived g row th facto r (PD G F) when the sa mples were solubili zed . Wh ether this increased ty rosyl kinase and ph osphatase acti v it y was actually du e to EGF, another kn own g row th factor such as PDGF, a v iru s o r o ncogene ty rosyl kin ase was not answe red. T he am o unt of ti ss ue required to prove th at the EGF recepto r kin ase activity is increased 2-fold prevented us fr o m res o lving this ques ti o n. Morpho m etric analysis of sil ver grains in the present study independently indicates a 2-fold. increase in f 125 1]EG F binding in the upper laye r of psoriati c e pidermis so that the m ost likely source o f the in creased ty rosyl kinase acti v it y in pso ri atic lesions is th at of the EGF receptor.
